Fragment-Based Screening Maps Inhibitor Interactions in the ATP-Binding Site of Checkpoint Kinase 2-Reference-Cited by-同舟云学术

Fragment-Based Screening Maps Inhibitor Interactions in the ATP-Binding Site of Checkpoint Kinase 2

Published:2013-06-12 Issue:6 Volume:8 Page:e65689
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Silva-Santisteban M. Cris,Westwood Isaac M.,Boxall Kathy,Brown Nathan,Peacock Sam,McAndrew Craig,Barrie Elaine,Richards Meirion,Mirza Amin,Oliver Antony W.,Burke Rosemary,Hoelder Swen,Jones Keith,Aherne G. Wynne,Blagg Julian,Collins Ian,Garrett Michelle D.,van Montfort Rob L. M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference85 articles.

1. CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?;L Antoni;Nature Rev Cancer,2007

2. Chk1 and Chk2 kinases in checkpoint control and cancer;J Bartek;Cancer Cell,2003

3. DNA damage-induced activation of p53 by the checkpoint kinase Chk2;A Hirao;Science,2000

4. Chk2 molecular interaction map and rationale for Chk2 inhibitors;Y Pommier;Clin Cancer Res,2006

5. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation;JY Ahn;Cancer Res,2000

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Assessment of Dispersion-Corrected DFT Methods for Modeling Nonbonded Interactions in Protein Kinase Inhibitor Complexes;Molecules;2024-01-06

2. Docking Based Screening of Potent Flavonoids as CHK2 Inhibitors from Genus Miliusa;Proceedings of the National Academy of Sciences, India Section B: Biological Sciences;2022-08-01

3. A benzimidazole derivative as an effective antitumor agent in terms of syngeneic lung tumors and melanoma treatment;South Russian Journal of Cancer;2022-02-21

4. Bicyclic 5-5 Systems With One Bridgehead (Ring Junction) Nitrogen Atom: Three Extra Heteroatoms 2:1;Comprehensive Heterocyclic Chemistry IV;2022

5. Benzimidazole derivative as antitumor drug against experimentally induced lung carcinoma;Bulletin of Russian State Medical University;2021-06